Cargando…
Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
BACKGROUND: Serum autoantibodies (AAbs) against tumor-associated antigens (TAAs) could be useful biomarkers for cancer detection. This study aims to evaluate the diagnostic value of autoantibody against PDLIM1 for improving the detection of ovarian cancer (OC). METHODS: Immunohistochemistry (IHC) te...
Autores principales: | Qiu, Cuipeng, Duan, Yaru, Wang, Bofei, Shi, Jianxiang, Wang, Peng, Ye, Hua, Dai, Liping, Zhang, Jianying, Wang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417125/ https://www.ncbi.nlm.nih.gov/pubmed/34489945 http://dx.doi.org/10.3389/fimmu.2021.698312 |
Ejemplares similares
-
Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
por: Duan, Yaru, et al.
Publicado: (2022) -
Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer
por: Cui, Chi, et al.
Publicado: (2021) -
Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020) -
Establishment and validation of an immunodiagnostic model for prediction of breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2019)